Oragenics Inc (OGEN):企業の財務・戦略的SWOT分析

【英語タイトル】Oragenics Inc (OGEN) - Financial and Strategic SWOT Analysis Review

GlobalDataが出版した調査資料(DATA904C5344)・商品コード:DATA904C5344
・発行会社(調査会社):GlobalData
・発行日:2018年9月
・ページ数:38
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Oragenics Inc (OGEN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Oragenics Inc (Oragenics) focuses on the development and commercialization of novel antibiotics against infectious disease that includes treatments for oral mucositis, healthcare associated infections, obesity and dental disorders. The company develops its product candidates based on various technologies such as Lantibiotics which is a class of antibiotics with a novel mechanism of action active against several multi-drug resistant organisms; live biotherapeutics, which utilizes genetically modified bacteria to treat oral indications and SMaRT Replacement Therapy which is based on the creation of genetically modified strain of bacteria colonizing in the oral cavity and replaces native bacteria that cause tooth decay. Oragenics is headquartered in Tampa, Florida, the US.

Oragenics Inc Key Recent Developments

Jul 19,2018: EKF Diagnostics Holdings manufacturing partnership with Oragenics
Apr 18,2017: Oragenics Provides First Quarter 2017 Update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Oragenics Inc – Key Facts 5
Oragenics Inc – Key Employees 6
Oragenics Inc – Key Employee Biographies 7
Oragenics Inc – Major Products and Services 8
Oragenics Inc – History 9
Oragenics Inc – Company Statement 12
Oragenics Inc – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Section 2 – Company Analysis 15
Company Overview 15
Oragenics Inc – Business Description 16
R&D Overview 16
Oragenics Inc – Corporate Strategy 17
Oragenics Inc – SWOT Analysis 18
SWOT Analysis – Overview 18
Oragenics Inc – Strengths 18
Oragenics Inc – Weaknesses 19
Oragenics Inc – Opportunities 20
Oragenics Inc – Threats 21
Oragenics Inc – Key Competitors 22
Section 3 – Company Financial Ratios 23
Financial Ratios – Capital Market Ratios 23
Financial Ratios – Annual Ratios 24
Performance Chart 26
Financial Performance 26
Financial Ratios – Interim Ratios 27
Financial Ratios – Ratio Charts 28
Section 4 – Company’s Lifesciences Financial Deals and Alliances 29
Oragenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
Oragenics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30
Oragenics Inc, Recent Deals Summary 31
Section 5 – Company’s Recent Developments 32
Jul 19, 2018: EKF Diagnostics Holdings manufacturing partnership with Oragenics 32
Apr 18, 2017: Oragenics Provides First Quarter 2017 Update 33
Section 6 – Appendix 34
Methodology 34
Ratio Definitions 34
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Oragenics Inc, Key Facts 5
Oragenics Inc, Key Employees 6
Oragenics Inc, Key Employee Biographies 7
Oragenics Inc, Major Products and Services 8
Oragenics Inc, History 9
Oragenics Inc, Other Locations 14
Oragenics Inc, Key Competitors 22
Oragenics Inc, Ratios based on current share price 23
Oragenics Inc, Annual Ratios 24
Oragenics Inc, Annual Ratios (Cont...1) 25
Oragenics Inc, Interim Ratios 27
Oragenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
Oragenics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30
Oragenics Inc, Recent Deals Summary 31
Currency Codes 34
Capital Market Ratios 34
Equity Ratios 35
Profitability Ratios 35
Cost Ratios 36
Liquidity Ratios 36
Leverage Ratios 37
Efficiency Ratios 37

List of Figures
Oragenics Inc, Performance Chart (2013 - 2017) 26
Oragenics Inc, Ratio Charts 28
Oragenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
Oragenics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 30

★調査レポート[Oragenics Inc (OGEN):企業の財務・戦略的SWOT分析] (コード:DATA904C5344)販売に関する免責事項を必ずご確認ください。
★調査レポート[Oragenics Inc (OGEN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆